Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Iquest Co., Ltd. (262840:KRX), powered by AI.
Iquest Co., Ltd. is currently trading at ₩3,085. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Iquest Co., Ltd. on Alpha Lenz.
Iquest Co., Ltd.'s P/E ratio is 5.8.
“Iquest Co., Ltd. trades at a P/E of 5.8 (undervalued) with solid ROE of 11.1%. 3Y revenue CAGR of 18.2% highlights clear growth momentum.”
Ask for details →Iquest Co., Ltd. is a company engaged in providing information technology services and solutions. Specializing in IT systems management, software development, and integration, the company plays a crucial role in enabling businesses to enhance their operational efficiency through technology. Iquest's offerings include consulting services, system integration, and tailored software solutions that cater to various industries including finance, healthcare, and retail. Key features of Iquest's services are their ability to streamline processes, improve data management, and provide scalable solutions to meet evolving business needs. In the financial market, Iquest Co., Ltd. represents an important component of the IT sector, contributing to the digital transformation of enterprises and supporting the infrastructure of a rapidly growing technological landscape. As businesses continue to prioritize digital capabilities, firms like Iquest are pivotal in delivering the expertise and technological support required for sustainable growth and development.
“Iquest Co., Ltd. trades at a P/E of 5.8 (undervalued) with solid ROE of 11.1%. 3Y revenue CAGR of 18.2% highlights clear growth momentum.”
Ask for details →Iquest Co., Ltd. (ticker: 262840) is a company listed on KRX in the Technology sector (Software - Application). It has approximately 107 employees. Market cap is $32.6B.
The current price is ₩3,085 with a P/E ratio of 5.81x and P/B of 0.62x.
ROE is 11.15% and operating margin is 9.81%. Annual revenue is $43.6B.